It's easy to forget about the underlying public service role of the field, the reason the press gets singled out for protection under the First Amendment.
Journalism at its best is about truth-telling, about providing people with information they need to understand their world. It's a deeply imperfect enterprise ��and a critically important one. And sometimes those carrying it out pay the ultimate price.
We were reminded of this powerfully last Friday when Anja Niedringhaus, a photographer for the Associated Press, and Kathy Gannon, an AP correspondent, were shot while covering the run-up to the election in Afghanistan. Niedringhaus died from her injuries.
Another reminder of journalism's heft came with the death Sunday of former Philadelphia Daily News columnist Chuck Stone, a man whose writing engendered such trust in the community that scores of criminal suspects surrendered to him rather than to the police, a man who once successfully negotiated a hostage situation at a prison at great personal risk.
Top 10 Low Price Companies To Buy Right Now: ATMI Inc.(ATMI)
ATMI, Inc. supplies high performance materials, materials packaging, and materials delivery systems for use in the manufacture of microelectronics devices worldwide. The company primarily offers front-end semiconductor performance materials; sub-atmospheric pressure gas delivery systems for safe handling and delivery of toxic and hazardous gases to semiconductor process equipment; and high-purity materials packaging and dispensing systems that allow for the reliable introduction of low volatility liquids and solids to microelectronics and biopharmaceutical processes. It also provides containment, mixing, and bioreactor technologies to the biotechnology, laboratory, and cell therapy markets. The company serves semiconductor and flat-panel display manufacturers, as well as the life sciences industry. It has strategic alliances with Enthone, Inc. and Lake LED Materials, Co., Ltd. The company was founded in 1986 and is headquartered in Danbury, Connecticut.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
ATMI (NASDAQ: ATMI) shot up 25.51 percent to $33.80 after the company reported upbeat Q4 earnings. Entegris (NASDAQ: ENTG) announced its plans to acquire ATMI. - [By Ben Axler]
In the table below, we've listed a sample of small-cap semiconductor capital equipment stocks such as Entegris (ENTG), Advanced Energy Industries (AEIS), ATMI Inc. (ATMI), MKS Instruments (MKSI), Photronics Inc. (PLAB), Rudolph Technologies (RTEC),FormFactor (FORM) and Mattson Technology (MTSN). The peers trade at approximately 1.0x and 15.5x 2014E revenues and EPS, respectively. Furthermore, the average peer trades at 2.1x tangible book value. However, these multiples are based on average 2014E industry revenue and earnings growth of 18% and 119%, respectively. Axcelis is poised to grow at a rate substantially above the industry average.
- [By Vanina Egea]
ATMI Inc. (ATMI)
Gabelli reported a stake of 1,193,900 shares of ATMI Inc., sized at 0.22% of his portfolio, and 3.75% of the company. It has a market cap of $1.08 billion; its shares are trading at $34.04 with a P/E ratio of 28.6 and P/S ratio of 2.77.
Top 10 Consumer Service Stocks To Watch For 2014: SIGA Technologies Inc.(SIGA)
SIGA Technologies, Inc., a pharmaceutical company, engages in the development and commercialization of pharmaceutical solutions for smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. Its lead product is ST-246, an orally administered antiviral drug that targets orthopoxviruses. The company also has two drug series in the pre-clinical development stage against four serotypes of virus for dengue disease. In addition, it is developing anti-arenavirus drug for hemorrhagic fever arenaviruses and other hemorrhagic fever viruses, including Rift Valley Fever, Lymphocytic choriomeningitis virus, and Ebola; and a broad spectrum antiviral candidate against viruses in the Poxviridae, Filoviridae, Bunyaviridae, Arenaviridae, Flaviviridae, Togaviridae, Retroviridae, and Picornaviridae families. The company was founded in 1995 and is headquartered in New York, New York.
Advisors' Opinion:- [By Monica Gerson]
SIGA Technologies (NASDAQ: SIGA) is expected to post its Q4 earnings at $0.62 per share on revenue of $47.00 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
- [By Roberto Pedone]
Another under-$10 name pharmaceutical player that's starting to move within range of triggering a big breakout trade is Siga Technologies (SIGA), which discovers, develops, manufactures and commercializes drugs to prevent and treat diseases including smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. This stock is off to a strong start in 2013, with shares up by 35%.
If you take a look at the chart for SIGA Technologies, you'll notice that this stock has been trending inside of a consolidation pattern for the last two months, with shares moving between $3.16 on the downside and $3.74 on the upside. Shares of SIGA have just started to spike higher above its 50-day moving average at $3.27 a share and it's now moving within range of triggering a big breakout trade above the upper-end of its recent range.
Market players should now look for long-biased trades in SIGA if it manages to break out above some near-term overhead resistance levels at $3.70 to $3.74 a share and then once it takes out more resistance at $4 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 263,209 shares. If that breakout triggers soon, then SIGA will set up to re-test or possibly take out its 52-week high at $4.60 a share. If that level gets taken out with volume, then SIGA could easily tag its next major overhead resistance levels at $5 to $5.90 a share.
Traders can look to buy SIGA off weakness to anticipate that breakout and simply use a stop that sits right below its 200-day moving average of $3.26 a share, or below more key support at $3.16 a share. One can also buy SIGA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Consumer Service Stocks To Watch For 2014: Take-Two Interactive Software Inc.(TTWO)
Take-Two Interactive Software, Inc. publishes, develops, and distributes interactive entertainment software, hardware, and accessories worldwide. The company develops and publishes software titles for various gaming and entertainment hardware platforms, including PlayStation3 and PlayStation2 computer entertainment systems, PlayStation Portable system, Xbox 360 video game and entertainment system, and Wii and DS systems, as well as for the personal computer and games for Windows. It offers products through its wholly owned labels Rockstar Games and 2K, which publishes titles under 2K Games, 2K Sports, and 2K Play. The company, through its subsidiary, Jack of All Games, also distributes software, hardware, and accessories in North America. Its proprietary brand franchises include Grand Theft Auto; Sid Meier's Civilization; Max Payne; Midnight Club; Manhunt; Red Dead Revolver; Bully; BioShock; Sid Meier's Railroads!; Sid Meier's Pirates!; Carnival Games; and Top Spin, as wel l as licensed brands comprise the sports games Major League Baseball 2K; NBA 2K; and NHL 2K. The company sells its software titles to retail outlets through direct relationships with large retail customers and third party distributors. Its customers include mass merchandisers, specialty retailers, video stores, electronics stores, toy stores, national and regional drug stores, and supermarket and discount store chains. The company was founded in 1993 and is headquartered in New York, New York.
Advisors' Opinion:- [By Rick Munarriz]
Take-Two Interactive (NASDAQ: TTWO ) is now just two months away from unleashing Grand Theft Auto V on hungry die-hard gamers.
It's going to be huge. The game play video released just two weeks ago has already been viewed nearly 18 million times. Video game sales have been slumping for four years, but watching Activision Blizzard (NASDAQ: ATVI ) set new sales records with every Call of Duty installment proves that there is still healthy interest in marquee releases.
- [By Dan Caplinger]
Next Monday, Take-Two Interactive (NASDAQ: TTWO ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed kneejerk reaction to news that turns out to be exactly the wrong move.
- [By Leo Sun]
Earlier this year, Superannuation estimated that Ubisoft's production budget for Watch Dogs had hit $68 million. Although that would be significantly less than Activision Blizzard's (NASDAQ: ATVI ) $140 million budget for Destiny and Take-Two's (NASDAQ: TTWO ) $265 million budget for GTA V, it still represents a very confident investment for a new IP.
- [By Christopher Freeburn]
On Tuesday, Rockstar Games, a subsidiary of Take-Two Interactive Software (TTWO), released its much anticipated Grand Theft Auto V. The game allows players to navigate a large city, interacting with various unsavory and often violent criminals as they carry out missions. Players get to take part in car chases, shoot-outs and assorted examples of mayhem. The game’s latest edition remains true to the spirit of gleeful carnage found in its previous iterations, USA TODAY notes.
Top 10 Consumer Service Stocks To Watch For 2014: Indus Motor Company Ltd (INDU)
Indus Motor Company Limited is a Pakistan-based company mainly engaged in the manufacture of automobiles and trucks. The Company is a joint-venture between the House of Habib, Toyota Motor Corporation and Toyota Tsusho Corporation for assembling, progressive manufacturing and marketing of Toyota-branded vehicles in Pakistan. It also acts as the sole distributor of Toyota-branded vehicles in Pakistan. In addition, the Company also acts as the sole distributor of Daihatsu-branded vehicles in Pakistan and has a license for assembling, progressive manufacturing and marketing of these vehicles in Pakistan. Advisors' Opinion:- [By Kelley Wright]
This theory can also be applied to the Dow Jones Industrial Average (INDU), which has also displayed a long-term, repetitive tendency to fluctuate between high and low dividend yield extremes. Indeed, looking at broad market behavior, we've seen three signs of Overvalued conditions.
- [By Carol Hymowitz]
When a CEO retires, most of the payout comes from shares accumulated in the tenure, Wood said. The Dow Jones Industrial Average (INDU) closed above 16,000 for the first time last week.
- [By Nikolaj Gammeltoft]
The S&P 500 dropped less than 0.1 percent to 1,691.65, its first weekly decline since June 21. The benchmark index reached a record on July 22 and climbed within 3 points of 1,700 for three straight days before retreating. The Dow Jones Industrial Average (INDU) added 15.09 points, or 0.1 percent, to 15,558.83.
- [By Jim Jubak]
At the close, the Standard & Poor's 500 index (SPX) was down 2.09% and the Dow Jones Industrial Average (INDU) was off 1.94%. Mexico was 1.33% lower and Brazilian stocks were down 1.1% in Sao Paulo. In Europe, the German DAX (DAX) had tumbled 2.48% by the close of that market; in Milan, Italian stocks were down 2.30%; and in Spain, the IBEX 35 index (IBEX) was lower by 3.64%.
Top 10 Consumer Service Stocks To Watch For 2014: Bridge Capital Holdings(BBNK)
Bridge Capital Holdings operates as the bank holding company for Bridge Bank, National Association that provides commercial and retail banking services to small and medium size commercial businesses, business professionals, and retail customers primarily in California. Its depository and corporate banking services comprise cash and treasury management solutions, interest-bearing term deposit accounts, checking accounts, ACH payment and wire solutions, fraud protection, remote deposit capture through Smart Deposit Express, courier services, and online banking. The company?s lending solutions include working capital lines of credit; structured finance (asset-based lending and factoring); small business administration loans; commercial real estate loans; energy project financing; growth capital loans; equipment financing; letters of credit; and corporate credit cards. In addition, it serves clients operating internationally through services, such as foreign exchange (FX paym ents and hedging); letters of credit; and export/import financing. The company operates two branch offices in the Silicon Valley region, as well as five loan production offices in San Francisco, Pleasanton, and Orange County, California; Dallas, Texas; and Reston, Virginia. Bridge Capital Holdings was founded in 2000 and is headquartered in San Jose, California.
Advisors' Opinion:- [By Louis Navellier]
While the tech companies get all the attention in Silicon Valley the banks who serve the region are seeing amazing growth as well. Bridge Capital Holdings (BBNK) is a bank with two branch offices in the Silicon Valley region, as well as five loan production offices in San Francisco and Pleasanton, California, Dallas, Texas, Reston, Virginia, and Boston, Massachusetts.
Top 10 Consumer Service Stocks To Watch For 2014: Atlatsa Resources Corp (ATL)
Atlatsa Resources Corporation is engaged in mining, exploration and development of mineral deposits located in the Bushveld Igneous Complex (BIC), South Africa. The principal business activity is the mining and exploration of platinum group metals (PGM), through its mineral property interests. The Company�� subsidiaries include N1C Resources Incorporation, Anooraq Minera Mexicana, N2C Resources Incorporation, Plateau Resources Proprietary Limited, Bokoni Holdings Proprietary Limited, Bokoni Mines Proprietary Limited, Boikgantsho Proprietary Limited, Kwanda Proprietary Limited, Ga-Phasha Proprietary Limited, Middlepunt Hill Management Services (Proprietary) Limited and Lebowa Platinum Mine Limited. Advisors' Opinion:- [By Roberto Pedone]
Another stock that's starting to move within range of triggering a big breakout trade is Atlatsa Resources (ATL), which engages in the mining, exploration and development of platinum group metals properties located in the Bushveld Igneous Complex in South Africa. This stock has been on fire so far in 2013, with shares up a whopping 198%.
If you take a look at the chart for Atlatsa Resources, you'll notice that this stock has been uptrending strong for the last two months and change, with shares soaring higher from its low of 28 cents per share to its intraday high of 46 cents per share. During that uptrend, shares of ATL have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of ATL have now started to take out some near-term overhead resistance levels at 43 cents to 44 cents per share. That move is quickly pushing shares of ATL within range of triggering another big breakout trade.
Market players should now look for long-biased trades in ATL if it manages to break out above its 52-week high at 50 cents per share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 170,178 shares. If that breakout hits soon, then ATL will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at 63 cents to 73 cents per share, or even 80 cents per share.
Traders can look to buy ATL off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of 39 cents per share, or near more support at 37 cents per share. One can also buy ATL off strength once it clears its 52-week high at 50 cents with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Consumer Service Stocks To Watch For 2014: Hyperion Therapeutics Inc (HPTX)
Hyperion Therapeutics, Inc. (Hyperion), incorporated in November 2006, is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD) and hepatic encephalopathy (HE). The Company has completed two Phase II trials and one pivotal Phase III trial of Ravicti. The Company�� HE clinical program consists of two trials, which have enrolled patients with cirrhosis. On December 23, 2011, the Company submitted a new drug application (NDA) for Ravicti for the chronic management of UCD in patients aged six years and above based on data from its pivotal Phase III trial in adult patients and the results of two Phase II trials, one in adults and one in pediatric patients aged 6 through 17 years. In June 2013, Hyperion Therapeutics Inc announced that the completion of its acquisition of BUPHENYL (sodium phenylbutyrate) Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International, Inc.
In June 2011, the Company completed a 24-month carcinogenicity study of Ravicti in rats. On March 22, 2012, pursuant to an asset purchase agreement (purchase agreement) with Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation, the Company purchased all of the worldwide rights to Ravicti. The Company also has an option to acquire all of Ucyclyd�� worldwide rights in BUPHENYL and AMMONUL (sodium phenylacetate and sodium benzoate) injection.
The Company conducted a pivotal Phase III trial of Ravicti in adult patients 18 years of age or older with UCD. The Company completed a second Phase II trial at five centers in North America in UCD patients aged 6 through 17 years. This trial includes two phases: a two-week, open-label, safety, tolerability, pharmacokinetic characteristics and ammonia control of Ravicti. The Co! mpany enrolled 77 adult and pediatric UCD patients in its two 12-month open-label safety studies, 69 of whom completed the studies. The Company conducted nonclinical genotoxicity and carcinogenicity studies to assess the tumorigenic potential of Ravicti in animals and to assess the relevant risk in humans. The Company is conducting a Phase II multi-center study of patients with cirrhosis and episodic HE.
Advisors' Opinion:- [By Jesse Solomon]
NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.
- [By Sean Williams]
What: Shares of Hyperion Therapeutics (NASDAQ: HPTX ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX ) .
No comments:
Post a Comment